Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Non-cash Items (2020 - 2022)

Caribou Biosciences has reported Non-cash Items over the past 3 years, most recently at $31.5 million for Q2 2022.

  • Quarterly Non-cash Items rose 503.54% to $31.5 million in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $31.5 million through Jun 2022, up 503.54% year-over-year, with the annual reading at $1.3 million for FY2021, 81.3% down from the prior year.
  • Non-cash Items was $31.5 million for Q2 2022 at Caribou Biosciences, up from $19.8 million in the prior quarter.
  • Over five years, Non-cash Items peaked at $50.1 million in Q4 2021 and troughed at $5.2 million in Q2 2021.
  • The 3-year median for Non-cash Items is $9.3 million (2021), against an average of $18.6 million.
  • Year-over-year, Non-cash Items surged 622.83% in 2021 and then surged 113.31% in 2022.
  • A 3-year view of Non-cash Items shows it stood at $6.9 million in 2020, then surged by 622.83% to $50.1 million in 2021, then plummeted by 37.11% to $31.5 million in 2022.
  • Per Business Quant, the three most recent readings for CRBU's Non-cash Items are $31.5 million (Q2 2022), $19.8 million (Q1 2022), and $50.1 million (Q4 2021).